Corinna Brungs

Corinna Brungs

Auto-generated profile, based on publicly available information

Corinna Brungs

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2024 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
SHSteffen Heuckeroth
Steffen Heuckeroth
TDTito Damiani
Tito Damiani
ASAleksandr Smirnov
Aleksandr Smirnov
OMOlena Mokshyna
Olena Mokshyna
CBCorinna Brungs
Corinna Brungs
TPTomáš Pluskal
Tomáš Pluskal

20 September 2024 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
ASAbzer K. Pakkir Shah
Abzer K. Pakkir Shah
AWAxel Walter
Axel Walter
FOFilip Ottosson
Filip Ottosson
Francesco RussoFrancesco Russo
Francesco Russo
MNMarcelo Navarro-Diaz
Marcelo Navarro-Diaz
DPDaniel Petras
Daniel Petras

23 May 2025 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
RBRoman Bushuiev
Roman Bushuiev
ABAnton Bushuiev
Anton Bushuiev
RSRaman Samusevich
Raman Samusevich
CBCorinna Brungs
Corinna Brungs
JSJosef Sivic
Josef Sivic
TPTomáš Pluskal
Tomáš Pluskal
Characterizing biological and environmental samples at a molecular level primarily uses tandem mass spectroscopy (MS/MS), yet the interpretation of tandem mass spectra from untargeted metabolomics experiments remains a challenge. Existing computational methods for predictions from mass spectra rely on limited spectral libraries and on hard-coded human expertise. Here we introduce a transformer-based neural network pre-trained in a self-supervised way on millions of unannotated tandem mass spectra from our GNPS Experimental Mass Spectra (GeMS) dataset mined from the MassIVE GNPS repository. We show that pre-training our model to predict masked spectral peaks and chromatographic retention orders leads to the emergence of rich representations of molecular structures, which we named Deep Representations Empowering the Annotation of Mass Spectra (DreaMS). Further fine-tuning the neural network yields state-of-the-art performance across a variety of tasks. We make our new dataset and model available to the community and release the DreaMS Atlas—a molecular network of 201 million MS/MS spectra constructed using DreaMS annotations.

15 September 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
CBCorinna Brungs
Corinna Brungs
RSRobin Schmid
Robin Schmid
SHSteffen Heuckeroth
Steffen Heuckeroth
AMAninda Mazumdar
Aninda Mazumdar
MDMatúš Drexler
Matúš Drexler
TPTomáš Pluskal
Tomáš Pluskal
Untargeted high-resolution mass spectrometry is a key tool in clinical metabolomics, natural product discovery and exposomics, with compound identification remaining the major bottleneck. Currently, the standard workflow applies spectral library matching against tandem mass spectrometry (MS 2 ) fragmentation data. Multi-stage fragmentation (MS n ) yields more profound insights into substructures, enabling validation of fragmentation pathways; however, the community lacks open MS n reference data of diverse natural products and other chemicals. Here we describe MS n Lib, a machine learning-ready open resource of >2 million spectra in MS n trees of 30,008 unique small molecules, built with a high-throughput data acquisition and processing pipeline in the open-source software mzmine.

28 February 2025 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
YAYasin El Abiead
Yasin El Abiead
Adriano RutzAdriano Rutz
Adriano Rutz
SZSimone Zuffa
Simone Zuffa
BABashar Amer
Bashar Amer
SXShipei Xing
Shipei Xing
PDPieter C. Dorrestein
Pieter C. Dorrestein

6 May 2024 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
MGMichael Giulbudagian
Michael Giulbudagian
BBBeatrice Battisini
Beatrice Battisini
WBWolfgang Bäumler
Wolfgang Bäumler
ARAna M. Blass Rico
Ana M. Blass Rico
BBBeatrice Bocca
Beatrice Bocca
PLPeter Laux
Peter Laux
Tattooing has been part of the human culture for thousands of years, yet only in the past decades has it entered the mainstream of the society. With the rise in popularity, tattoos also gained attention among researchers, with the aim to better understand the health risks posed by their application. ‘A medical‐toxicological view of tattooing’—a work published in The Lancet almost a decade ago, resulted from the international collaboration of various experts in the field. Since then, much understanding has been achieved regarding adverse effects, treatment of complications, as well as their regulation for improving public health. Yet major knowledge gaps remain. This review article results from the Second International Conference on Tattoo Safety hosted by the German Federal Institute for Risk Assessment (BfR) and provides a glimpse from the medical‐toxicological perspective, regulatory strategies and advances in the analysis of tattoo inks.